What is Allstate Corp's earnings per share (EPS)?

Allstate Corp (ALL) reported diluted earnings per share of $38.06 for fiscal year 2025. This represents a 124.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Allstate Corp Financials

ALL

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Allstate Corp (ALL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALL FY2025 2026-04-29

Cash generation stayed durable through loss years, and the recent profit rebound is arriving with lower leverage.

The key change is earnings now matching cash generation: after a combined -$1.7B of net losses in FY2022-FY2023, the company still produced about $9.3B of operating cash flow. By FY2025, net income reached $10.2B and operating cash flow $10.1B, so the recovery is showing up in cash, not only in accounting profit.

The balance sheet is funded more by broad liabilities than by debt: FY2025 liabilities were $89.2B, but long-term debt was only $7.5B, while debt-to-equity fell from 0.46x in FY2022 to 0.24x. That means the jump to a 33.2% ROE came with less financial leverage, not more.

Capital intensity is low relative to the cash engine: FY2025 capital spending was just $228M against $10.1B of operating cash flow, leaving most cash available for shareholder payouts and balance-sheet rebuilding. That helps explain why free cash flow stayed robust even when earnings did not, and why free-cash-flow margin expanded from 6.9% in FY2023 to 14.6% in FY2025.

Financial Health Signals

Financial Profile 44/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Allstate Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Allstate Corp's revenue grew 5.6% year-over-year to $67.7B, a solid pace of expansion. This earns a growth score of 48/100.

Leverage

Allstate Corp carries a low D/E ratio of 0.24, meaning only $0.24 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 97/100, indicating a strong balance sheet with room for future borrowing.

Cash Flow

Allstate Corp has a free cash flow margin of 14.6%, earning a moderate score of 57/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Allstate Corp's ROE of 33.2% shows moderate profitability relative to equity, earning a score of 61/100. This is up from 21.2% the prior year.

Piotroski F-Score Neutral

5/9

Allstate Corp passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

0.99x

For every $1 of reported earnings, Allstate Corp generates $0.99 in operating cash flow ($10.1B OCF vs $10.2B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$67.7B

YoY+5.6%

5Y CAGR+10.1%

10Y CAGR+6.6%

Allstate Corp generated $67.7B in revenue in fiscal year 2025. This represents an increase of 5.6% from the prior year.

EBITDA

N/A

Net Income

$10.2B

YoY+123.4%

5Y CAGR+12.8%

10Y CAGR+16.7%

Allstate Corp reported $10.2B in net income in fiscal year 2025. This represents an increase of 123.4% from the prior year.

EPS (Diluted)

$38.06

YoY+124.0%

5Y CAGR+17.1%

10Y CAGR+22.4%

Allstate Corp earned $38.06 per diluted share (EPS) in fiscal year 2025. This represents an increase of 124.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$9.9B

YoY+13.3%

5Y CAGR+13.8%

10Y CAGR+11.5%

Allstate Corp generated $9.9B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 13.3% from the prior year.

Cash & Debt

$678.0M

YoY-3.7%

5Y CAGR+16.9%

10Y CAGR+3.2%

Allstate Corp held $678.0M in cash against $7.5B in long-term debt as of fiscal year 2025.

Dividends Per Share

$4.00

YoY+8.7%

5Y CAGR+13.1%

10Y CAGR+12.8%

Allstate Corp paid $4.00 per share in dividends in fiscal year 2025. This represents an increase of 8.7% from the prior year.

Shares Outstanding

260M

YoY-2.1%

5Y CAGR-3.0%

10Y CAGR-3.7%

Allstate Corp had 260M shares outstanding in fiscal year 2025. This represents a decrease of 2.1% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

15.0%

YoY+7.9pp

5Y CAGR+1.7pp

10Y CAGR+8.9pp

Allstate Corp's net profit margin was 15.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 7.9 percentage points from the prior year.

Return on Equity

33.2%

YoY+12.0pp

5Y CAGR+14.8pp

10Y CAGR+22.4pp

Allstate Corp's ROE was 33.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 12.0 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$1.2B

YoY+61550.0%

5Y CAGR-6.6%

10Y CAGR-7.9%

Allstate Corp spent $1.2B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 61550.0% from the prior year.

Capital Expenditures

$228.0M

YoY+8.6%

5Y CAGR-5.8%

10Y CAGR-2.8%

Allstate Corp invested $228.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 8.6% from the prior year.

ALL Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$67.7B+5.6%	$64.1B+12.3%	$57.1B+11.1%	$51.4B+1.6%	$50.6B+20.7%	$41.9B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$399.0M-0.3%	$400.0M+5.5%	$379.0M+13.1%	$335.0M+1.5%	$330.0M+3.8%	$318.0M
Income Tax	$2.9B+148.7%	$1.2B+960.7%	-$135.0M+72.3%	-$488.0M-137.8%	$1.3B-5.9%	$1.4B
Net Income	$10.2B+123.4%	$4.5B+1539.9%	-$316.0M+77.7%	-$1.4B-195.4%	$1.5B-73.4%	$5.6B
EPS (Diluted)	$38.06+124.0%	$16.99+1515.8%	$-1.20+76.7%	$-5.14-202.6%	$5.01-71.1%	$17.31

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$16.9B-2.3%	$17.3B+0.5%	$17.3B+3.7%	$16.6B+1.1%	$16.5B-0.3%	$16.5B-0.7%	$16.6B+5.8%	$15.7B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$98.0M	N/A	$101.0M+1.0%	$100.0M0.0%	$100.0M	N/A	$104.0M+6.1%	$98.0M
Income Tax	$650.0M	N/A	$1.1B+78.0%	$604.0M+391.1%	$123.0M	N/A	$254.0M+206.0%	$83.0M
Net Income	$2.5B-35.4%	$3.8B+1.5%	$3.7B+77.6%	$2.1B+254.5%	$595.0M-68.7%	$1.9B+59.6%	$1.2B+259.5%	$331.0M
EPS (Diluted)	$9.25-35.6%	$14.37+3.0%	$13.95+79.8%	$7.76+267.8%	$2.11-70.2%	$7.07+63.3%	$4.33+283.2%	$1.13

ALL Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$119.8B+7.3%	$111.6B+8.0%	$103.4B+5.5%	$98.0B-1.5%	$99.4B-21.1%	$126.0B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$678.0M-3.7%	$704.0M-2.5%	$722.0M-1.9%	$736.0M-3.5%	$763.0M+145.3%	$311.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$3.1B-3.9%	$3.2B-7.3%	$3.5B0.0%	$3.5B0.0%	$3.5B+47.8%	$2.4B
Total Liabilities	$89.2B-1.2%	$90.3B+5.3%	$85.7B+6.3%	$80.6B+8.5%	$74.3B-22.4%	$95.8B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$7.5B-7.4%	$8.1B+1.8%	$7.9B-0.3%	$8.0B-0.2%	$8.0B+1.9%	$7.8B
Total Equity	$30.6B+42.8%	$21.4B+20.7%	$17.8B+1.6%	$17.5B-29.9%	$24.9B-17.5%	$30.2B
Retained Earnings	$62.4B+17.1%	$53.3B+7.2%	$49.7B-2.5%	$51.0B-4.4%	$53.3B+1.0%	$52.8B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$124.0B+3.5%	$119.8B-0.5%	$120.4B+3.9%	$115.9B+0.6%	$115.2B+3.2%	$111.6B-1.9%	$113.7B+5.0%	$108.4B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$697.0M+2.8%	$678.0M-27.2%	$931.0M-6.4%	$995.0M+18.5%	$840.0M+19.3%	$704.0M-13.7%	$816.0M+36.2%	$599.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$3.1B0.0%	$3.1B0.0%	$3.1B0.0%	$3.1B+0.1%	$3.1B-4.0%	$3.2B+1.2%	$3.2B-8.5%	$3.5B
Total Liabilities	$92.4B+3.6%	$89.2B-4.0%	$92.9B+1.1%	$91.9B-1.3%	$93.1B+3.2%	$90.3B-2.9%	$92.9B+3.5%	$89.8B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$7.5B0.0%	$7.5B-7.4%	$8.1B0.0%	$8.1B0.0%	$8.1B0.0%	$8.1B0.0%	$8.1B0.0%	$8.1B
Total Equity	$31.6B+3.3%	$30.6B+11.3%	$27.5B+14.5%	$24.0B+8.9%	$22.1B+2.9%	$21.4B+2.7%	$20.9B+12.3%	$18.6B
Retained Earnings	$64.5B+3.4%	$62.4B+6.0%	$58.9B+6.2%	$55.4B+3.4%	$53.6B+0.6%	$53.3B+3.2%	$51.6B+1.8%	$50.7B

ALL Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$10.1B+13.2%	$8.9B+111.2%	$4.2B-17.4%	$5.1B+0.1%	$5.1B-6.8%	$5.5B
Capital Expenditures	$228.0M+8.6%	$210.0M-21.3%	$267.0M-36.4%	$420.0M+21.7%	$345.0M+12.0%	$308.0M
Free Cash Flow	$9.9B+13.3%	$8.7B+120.2%	$4.0B-15.7%	$4.7B-1.5%	$4.8B-7.9%	$5.2B
Investing Cash Flow	-$7.3B+12.1%	-$8.3B-175.2%	-$3.0B-73.6%	-$1.7B-438.8%	$510.0M+114.8%	-$3.4B
Financing Cash Flow	-$2.9B-313.3%	-$697.0M+43.9%	-$1.2B+63.7%	-$3.4B+34.7%	-$5.2B-160.6%	-$2.0B
Dividends Paid	$1.0B+7.7%	$962.0M+4.0%	$925.0M-0.1%	$926.0M+4.6%	$885.0M+32.5%	$668.0M
Share Buybacks	$1.2B+61550.0%	$2.0M-99.4%	$335.0M-86.7%	$2.5B-19.2%	$3.1B+79.6%	$1.7B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$3.6B+19.2%	$3.0B-9.0%	$3.3B+75.3%	$1.9B-4.6%	$2.0B+15.2%	$1.7B-46.7%	$3.2B+35.7%	$2.4B
Capital Expenditures	$40.0M-55.1%	$89.0M+85.4%	$48.0M+4900.0%	-$1.0M-101.1%	$92.0M+84.0%	$50.0M-20.6%	$63.0M+12.5%	$56.0M
Free Cash Flow	$3.5B+21.4%	$2.9B-10.4%	$3.2B+72.9%	$1.9B0.0%	$1.9B+13.1%	$1.7B-47.3%	$3.1B+36.3%	$2.3B
Investing Cash Flow	-$2.6B-34.8%	-$1.9B+30.5%	-$2.8B-132.2%	-$1.2B+6.6%	-$1.3B+22.6%	-$1.7B+37.8%	-$2.7B-6.4%	-$2.5B
Financing Cash Flow	-$916.0M+29.2%	-$1.3B-103.9%	-$634.0M-2.3%	-$620.0M-85.6%	-$334.0M-28.5%	-$260.0M-40.5%	-$185.0M-115.1%	-$86.0M
Dividends Paid	$261.0M-0.8%	$263.0M-0.4%	$264.0M-0.4%	$265.0M+8.6%	$244.0M+0.4%	$243.0M0.0%	$243.0M0.0%	$243.0M
Share Buybacks	$614.0M+41.5%	$434.0M+20.6%	$360.0M+5.9%	$340.0M+243.4%	$99.0M+4850.0%	$2.0M	$0	$0

ALL Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	15.0%+7.9pp	7.1%+7.6pp	-0.5%+2.2pp	-2.8%-5.7pp	2.9%-10.4pp	13.3%
Return on Equity	33.2%+12.0pp	21.2%+23.0pp	-1.8%+6.3pp	-8.1%-14.1pp	5.9%-12.5pp	18.4%
Return on Assets	8.5%+4.4pp	4.1%+4.4pp	-0.3%+1.1pp	-1.5%-2.9pp	1.5%-2.9pp	4.4%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.24-0.1	0.38-0.1	0.450.0	0.46+0.1	0.32+0.1	0.26
FCF Margin	14.6%+1.0pp	13.6%+6.7pp	6.9%-2.2pp	9.1%-0.3pp	9.4%-2.9pp	12.4%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	14.5%-7.4pp	21.9%+0.2pp	21.7%+9.0pp	12.7%+9.1pp	3.6%-7.9pp	11.5%+4.3pp	7.2%+5.0pp	2.1%
Return on Equity	7.8%-4.7pp	12.4%-1.2pp	13.6%+4.8pp	8.8%+6.1pp	2.7%-6.2pp	8.9%+3.2pp	5.7%+3.9pp	1.8%
Return on Assets	2.0%-1.2pp	3.2%+0.1pp	3.1%+1.3pp	1.8%+1.3pp	0.5%-1.2pp	1.7%+0.7pp	1.1%+0.7pp	0.3%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.240.0	0.24-0.0	0.29-0.0	0.34-0.0	0.37-0.0	0.38-0.0	0.39-0.0	0.43
FCF Margin	20.8%+4.1pp	16.7%-2.0pp	18.8%+7.5pp	11.3%-0.1pp	11.4%+1.3pp	10.0%-8.8pp	18.9%+4.2pp	14.7%

Similar Companies

Travelers Compan TRV

$65.9B

The Hartford Insurance Group Inc HIG

$38.0B

Chubb Limited CB

$128.3B

W.R Berkley WRB

$26.2B

Markel Corporation MKL

$24.0B

Frequently Asked Questions

What is Allstate Corp's annual revenue?

Allstate Corp (ALL) reported $67.7B in total revenue for fiscal year 2025. This represents a 5.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Allstate Corp's revenue growing?

Allstate Corp (ALL) revenue grew by 5.6% year-over-year, from $64.1B to $67.7B in fiscal year 2025.

Is Allstate Corp profitable?

Yes, Allstate Corp (ALL) reported a net income of $10.2B in fiscal year 2025, with a net profit margin of 15.0%.

How much debt does Allstate Corp have?

As of fiscal year 2025, Allstate Corp (ALL) had $678.0M in cash and equivalents against $7.5B in long-term debt.

What is Allstate Corp's net profit margin?

Allstate Corp (ALL) had a net profit margin of 15.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Allstate Corp pay dividends?

Yes, Allstate Corp (ALL) paid $4.00 per share in dividends during fiscal year 2025.

What is Allstate Corp's return on equity (ROE)?

Allstate Corp (ALL) has a return on equity of 33.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Allstate Corp's free cash flow?

Allstate Corp (ALL) generated $9.9B in free cash flow during fiscal year 2025. This represents a 13.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Allstate Corp's operating cash flow?

Allstate Corp (ALL) generated $10.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Allstate Corp's total assets?

Allstate Corp (ALL) had $119.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Allstate Corp's capital expenditures?

Allstate Corp (ALL) invested $228.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Allstate Corp buy back shares?

Yes, Allstate Corp (ALL) spent $1.2B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Allstate Corp have outstanding?

Allstate Corp (ALL) had 260M shares outstanding as of fiscal year 2025.

What is Allstate Corp's debt-to-equity ratio?

Allstate Corp (ALL) had a debt-to-equity ratio of 0.24 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Allstate Corp's return on assets (ROA)?

Allstate Corp (ALL) had a return on assets of 8.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Allstate Corp's Piotroski F-Score?

Allstate Corp (ALL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Allstate Corp's earnings high quality?

Allstate Corp (ALL) has an earnings quality ratio of 0.99x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Allstate Corp?

Allstate Corp (ALL) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.